1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 

Patient demographics, diagnosis, and clinical course
No.Age (yr)SexInitial Pathology (date)Follow-Up Intervalsa (mo)DiagnosisbReference Standard
130FGBM, May 20036 and 9RTBiopsy
230MOligodendroglioma, March 20084 and 8RTClinical/MRI follow-up
359FOligodendroglioma, May 200524 and 26SDClinical/MRI follow-up
463FGBM, February 200810 and 12SDClinical/MRI follow-up
561MGBM, June 20082 and 4RTClinical/MRI follow-up
657MAstrocytoma,c August 20081 and 3RTClinical/MRI follow-up
755MGBM, May 20087 and 9SDClinical/MRI follow-up
844FOligodendroglioma, 19966 and 8RTBiopsy
929FGBM, October 20066 and 8RTBiopsy
1048FGBM, September 20054 and 5SDdClinical/MRI follow-up
1192FGBM, November 20073 and 7RT PseudoDeceased
1236MGBM, November 20074 and 5SDdClinical/MRI follow-up
1353FAstrocytoma,c May 20086 and 10SDClinical/MRI follow-up
1462MAstrocytoma,c October 20086 and 8RTBiopsy
1560MGBM4 and 7RTBiopsy
1642FGBM, April 20091 and 3RTClinical/MRI follow-up
1771MGBM, October 20081 and 3RTClinical/MRI follow-up
  •  

    a Scanning follow-up intervals after treatment for new enhancing lesions.
  •  

    b Most probable diagnosis of new lesions: GBM, RT, SD (most likely radiation-chemotherapy change).
  •  

    c Anaplastic astrocytoma.
  •  

    d Patients underwent additional MR imaging showing no change in radiologic features or change in clinical status.